TEVOGEN BIO HOLDINGS INC.

Highlights Tevogen Bio Holdings Inc.

Equities

TVGN

US88165K1016

Delayed Nasdaq Other stock markets 07:29:17 27/06/2024 pm IST			5-day change	1st Jan Change
0.7338 ^USD	-2.16%		-2.81%	-93.41%

25/06	Tevogen Bio Holdings Inc. Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances	CI
24/06	Tevogen Bio Holdings Inc.(NasdaqGM:TVGN) added to S&P TMI Index	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tevogen Bio Holdings Inc. Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances	25/06	CI
Tevogen Bio Confirms Ongoing Efficacy of Tvgn 489, Its Investigational Allogeneic Off-The-Shelf Immunotherapy, Against Dominant Flirt Strains of Sars-Cov-2	07/06	CI
Top Premarket Gainers	13/05	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	26/04	MT
Tevogen Bio Shares Jump Following Report on $94.9 Million Liability Elimination	26/04	MT
Top Premarket Gainers	26/04	MT
Tevogen Bio Holdings Announces TVGN 489, its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant	20/03	CI
Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment	21/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer